BioLineRx (BLRX) Institutional Ownership → Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad) Free BLRX Stock Alerts $0.66 -0.01 (-1.49%) (As of 05/2/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for BioLineRx (NASDAQ:BLRX)CurrentInstitutional OwnershipPercentage1.56%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$379.08KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$837.14K Get BLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioLineRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLRX Institutional Buying and Selling by Quarter Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. BioLineRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/12/2024PVG Asset Management Corp61,840$97K0.5%N/A0.085% 2/8/2024NorthRock Partners LLC17,125$27K0.0%N/A0.024% 12/1/2023B. Riley Wealth Advisors Inc.21,300$39K0.0%+88.5%0.029% 11/21/2023 Allen Mooney & Barnes Investment Advisors LLC25,000$46K0.0%N/A0.035% 11/13/2023Rathbones Group PLC39,820$72K0.0%N/A0.065% 11/8/2023 Values First Advisors Inc.48,348$88K0.1%N/A0.079% Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 10/11/2023Geneos Wealth Management Inc.40,500$74K0.0%+72.3%0.066% 7/31/2023PVG Asset Management Corp61,840$99K0.4%-52.0%0.101% 5/16/2023Altium Capital Management LP2,279,657$2.02M1.1%-26.5%3.705% 11/14/2022Armistice Capital LLC2,797,048$2.59M0.0%N/A4.546% 11/14/2022Altium Capital Management LP4,149,262$3.84M1.4%N/A6.744% 11/8/2022Apollon Wealth Management LLC48,790$45K0.0%N/A0.079% 11/7/2022Virtu Financial LLC46,168$43K0.0%+195.6%0.075% 10/13/2022PVG Asset Management Corp47,860$44K0.2%N/A0.100% 7/22/2022Geneos Wealth Management Inc.41,450$53K0.0%+25.8%0.087% 5/13/2022Parkman Healthcare Partners LLC270,665$463K0.1%-36.9%0.568% 2/9/2022Geneos Wealth Management Inc.28,950$59K0.0%+63.1%0.061% 2/4/2022Envestnet Asset Management Inc.122,224$249K0.0%+184.7%0.256% 2/2/2022PVG Asset Management Corp160,360$327K1.2%+109.6%0.336% 1/28/2022 ARK Investment Management LLC1,059,722$2.16M0.0%-1.3%2.223% 11/16/2021Schonfeld Strategic Advisors LLC12,100$33K0.0%N/A0.025% 11/16/2021Intellectus Partners LLC28,500$78K0.0%-29.6%0.060% 11/12/2021Parkman Healthcare Partners LLC411,060$1.13M0.3%-44.0%0.869% 11/10/2021PVG Asset Management Corp76,510$210K0.6%N/A0.162% 10/26/2021 Game Plan Financial Advisors LLC25,000$69K0.0%-13.8%0.053% 9/17/2021Virtu Financial LLC16,578$47K0.0%N/A0.035% 8/13/2021Renaissance Technologies LLC77,808$219K0.0%-84.6%0.165% 8/11/2021Susquehanna Fundamental Investments LLC19,026$53K0.0%-74.5%0.040% 8/9/2021 Cutter & CO Brokerage Inc.18,667$52K0.0%-34.9%0.039% 5/18/2021Morgan Stanley398,412$1.11M0.0%-45.6%0.875% 5/18/2021First Heartland Consultants Inc.10,000$28K0.0%N/A0.023% 5/18/2021Silverarc Capital Management LLC200,000$558K0.3%N/A0.465% 5/17/2021Schonfeld Strategic Advisors LLC76,500$213K0.0%+115.5%0.178% 5/17/2021Intellectus Partners LLC40,500$113K0.0%N/A0.094% 5/17/2021Goldman Sachs Group Inc.16,621$46K0.0%N/A0.039% 5/13/2021Renaissance Technologies LLC505,121$1.41M0.0%+89.2%1.174% 4/28/2021 Game Plan Financial Advisors LLC26,000$74K0.0%N/A0.061% 2/12/2021LPL Financial LLC42,876$108K0.0%+154.1%0.111% 2/10/2021Rhumbline Advisers14,208$36K0.0%N/A0.037% 1/4/2021 Thomasville National Bank20,325$51K0.0%+62.6%0.089% The biggest energy story ever? (Ad)Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…For the full story, click here.11/13/2020Morgan Stanley768,335$1.26M0.0%+36.0%3.796% 11/5/2020 Cutter & CO Brokerage Inc.29,000$48K0.0%+62.9%0.145% 8/14/2020Opaleye Management Inc.16,667$29K0.0%N/A0.223% 8/14/2020BVF Inc. IL1,686,375$2.88M0.2%-2.7%22.551% 8/12/2020Goldman Sachs Group Inc.37,873$65K0.0%N/A0.506% 7/29/2020Psagot Investment House Ltd.117,000$200K0.0%N/A1.564% 5/15/2020Jane Street Group LLC52,043$77K0.0%N/A0.696% 5/15/2020Morgan Stanley343,909$457K0.0%+34.3%4.599% 5/14/2020Senvest Management LLC523,819$697K0.1%-16.7%7.005% (Data available from 1/1/2016 forward) BLRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLRX shares? During the previous two years, 12 institutional investors and hedge funds held shares of BioLineRx. The most heavily invested institutionals were Armistice Capital LLC ($2.59M), Altium Capital Management LP ($2.02M), Parkman Healthcare Partners LLC ($463K), PVG Asset Management Corp ($97K), Values First Advisors Inc. ($88K), Geneos Wealth Management Inc. ($74K), and Rathbones Group PLC ($72K).Learn more on BLRX's institutional investors. What percentage of BioLineRx stock is owned by institutional investors? 1.56% of BioLineRx stock is owned by institutional investors. Learn more on BLRX's institutional investor holdings. Which institutional investors have been buying BioLineRx stock? Of the 11 institutional investors that purchased BioLineRx stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Altium Capital Management LP ($4.15M), Armistice Capital LLC ($2.80M), PVG Asset Management Corp ($109.70K), Apollon Wealth Management LLC ($48.79K), Values First Advisors Inc. ($48.35K), Rathbones Group PLC ($39.82K), and Virtu Financial LLC ($30.55K). How much institutional buying is happening at BioLineRx? Institutional investors have bought a total of 7,301,144 shares in the last 24 months. This purchase volume represents approximately $6.93M in transactions. Which BioLineRx major shareholders have been selling company stock? The following institutional investors have sold BioLineRx stock in the last 24 months: Altium Capital Management LP ($823.98K), Parkman Healthcare Partners LLC ($157.94K), and PVG Asset Management Corp ($66.89K). How much institutional selling is happening at BioLineRx? Institutional investors have sold a total of 1,048,805 shares in the last 24 months. This volume of shares sold represents approximately $1.11M in transactions. Related Companies: CKPT Institutional Ownership CALC Institutional Ownership ELDN Institutional Ownership IMRX Institutional Ownership FIXX Institutional Ownership GANX Institutional Ownership RPHM Institutional Ownership AADI Institutional Ownership RMTI Institutional Ownership KRON Institutional Ownership This page (NASDAQ:BLRX) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsTruth about Trump you’ve never heardPorter & CompanyHe Is Giving Away BitcoinCrypto Swap ProfitsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithAI “wealth window” is closing June 25thParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.